Pei-Jung Lu

Personal profile

Education

1997 PhD, Pharmaceutical Science, Department of Pharmaceutical Science, College of Pharmacy, University of Kentucky

Experience

1998.01~2001.02 Postdoctoral Research/Harvard Medical School/Harvard University
2001.02~2002.02 Assistant Professor/Insititue of Biomedical Sciences, National Sun Yat-sen University
2002.02~2003.07 Associate Professor/Insititue of Biomedical Sciences, National Sun Yat-sen University
2003.08~2007.07 Associate Researcher/Kaohsiung Veterans General Hospital
2007.08~2010.07 Associate Professor/Institute of Clinical Medicine, NCKU
2009.08~2013.07 Professor/ Institute of Clinical Medicine, NCKU
2013.08~Present Distinguished Professor/ Institute of Clinical Medicine, NCKU

Research Interests

Signal Transduction
Tumor Biology
Neurodegeneration

Fingerprint Dive into the research topics where Pei-Jung Lu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Phosphorylation Medicine & Life Sciences

Solitary Nucleus Medicine & Life Sciences

Cells Chemical Compounds

Neoplasms Medicine & Life Sciences

Phosphatidylinositols Chemical Compounds

Proteins Medicine & Life Sciences

Apoptosis Medicine & Life Sciences

Glycogen Synthase Kinase 3 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

探討在三陰性乳癌轉移中的lncRNAs和miRNAs的交互作用

Lu, P.

19-08-01 → 20-07-31

Project: Research project

以肺癌為模式探討Rab37在囊泡運輸及抑癌機制中之角色-Rab37蛋白在抑制癌症幹性之角色(3/3)

Lu, P.

17-08-01 → 18-07-31

Project: Research project

CTMP/AKT訊息傳遞路徑促使三陰性乳癌轉移

Lu, P.

17-08-01 → 18-07-31

Project: Research project

CTMP/AKT訊息傳遞路徑促使三陰性乳癌轉移

Lu, P.

16-08-01 → 17-07-31

Project: Research project

以肺癌為模式探討Rab37在囊泡運輸及抑癌機制中之角色-Rab37蛋白在抑制癌症幹性之角色(2/3)

Lu, P.

16-08-01 → 17-07-31

Project: Research project

Research Output 1994 2019

6325 Citations
39 h-Index
158 Article
2 Review article
1 Comment/debate

High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma

Lin, C. H., Li, H. Y., Liu, Y. P., Kuo, P. F., Wang, W. C., Lin, F. C., Chang, W. L., Sheu, B. S., Wang, Y. C., Hung, W. C., Cheng, H. C., Yao, Y. C., Calkins, M. J., Hsiao, M. & Lu, P. J., 2019 Jan 1, In : Therapeutic Advances in Medical Oncology. 11

Research output: Contribution to journal › Article

Open Access

Stem Cells

Fursultiamin

Neoplasms

Therapeutics

Neoplastic Stem Cells

8 Citations (Scopus)

A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer

Wang, P. S., Chou, C. H., Lin, C. H., Yao, Y. C., Cheng, H. C., Li, H. Y., Chuang, Y. C., Yang, C. N., Ger, L. P., Chen, Y. C., Lin, F-C., Shen, T. L., Hsiao, M. & Lu, P-J., 2018 Aug 23, In : Oncogene. 37, 34, p. 4662-4678 17 p.

Research output: Contribution to journal › Article

Long Noncoding RNA

Triple Negative Breast Neoplasms

Neoplasm Metastasis

Lung

Nucleotides

3 Citations (Scopus)

Rab37 mediates exocytosis of secreted frizzled-related protein 1 to inhibit Wnt signaling and thus suppress lung cancer stemness

Cho, S., Kuo, I., Lu, P. F., Tzeng, H., Lai, W., Su, W. & Wang, Y., 2018 Sep 1, In : Cell death & disease. 9, 9

Research output: Contribution to journal › Article

3 Citations (Scopus)

A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma

Chang, W-L., Lai, W-W., Kuo, I. Y., Lin, C. Y., Lu, P-J., Sheu, B-S. & Wang, Y-C., 2017 Jun 1, In : Journal of Gastroenterology. 52, 6, p. 705-714 10 p.

Research output: Contribution to journal › Article

Chemoradiotherapy

DNA Methylation

Biomarkers

Methylation

Therapeutics

5 Citations (Scopus)

CTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patient

Chen, Y. C., Li, H. Y., Liang, J. L., Ger, L. P., Chang, H. T., Hsiao, M., Calkins, M. J., Cheng, H. C., Chuang, J. H. & Lu, P-J., 2017 Jan 1, In : Oncotarget. 8, 18, p. 29699-29710 12 p.

Research output: Contribution to journal › Article

Biomarkers

Breast Neoplasms

Trastuzumab

Sirolimus

Disease-Free Survival